[EN] PROBENECID COMPOUNDS FOR THE TREATMENT OF INFLAMMASOME-MEDIATED LUNG DISEASE [FR] COMPOSÉS DE PROBÉNÉCIDE POUR LE TRAITEMENT D'UNE MALADIE PULMONAIRE À MÉDIATION PAR INFLAMMASOMES
Aryl stannanes are valuable precursors in organic transformations, but their synthetic methods are limited. Here we present a Pd‐catalyzed decarbonylative stannylation of acid fluorides in the absence of exogenous base. Various aryl stannanes were efficiently prepared from bench‐stable transitionmetal catalyst and ligand with broad functional group compatibility and substrate scope including natural
[EN] PROBENECID COMPOUNDS FOR THE TREATMENT OF INFLAMMASOME-MEDIATED LUNG DISEASE<br/>[FR] COMPOSÉS DE PROBÉNÉCIDE POUR LE TRAITEMENT D'UNE MALADIE PULMONAIRE À MÉDIATION PAR INFLAMMASOMES
申请人:BACAINN BIOTHERAPEUTICS INC
公开号:WO2022005881A1
公开(公告)日:2022-01-06
Disclosed herein are methods, compounds, and compositions for treating or preventing inflammasome-mediated diseases or conditions, including inflammasome-mediated lung diseases or conditions.